A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Other news to note for Feb. 23, 2026
Other news to note for Feb. 23, 2026
Regulatory actions for Feb. 23, 2026
Regulatory actions for Feb. 23, 2026
Gilead brings Arcellx fully under the fold
Gilead brings Arcellx fully under the fold
Vanda gets FDA nod for atypical antipsychotic Bysanti
Vanda gets FDA nod for atypical antipsychotic Bysanti
Biggest gainers and losers for Feb. 16-20, 2026
Biggest gainers and losers for Feb. 16-20, 2026
Brise Pharmaceutical synthesizes new TRPM3 antagonists
Brise Pharmaceutical synthesizes new TRPM3 antagonists
Bioversys tuberculosis combo targets drug resistance
Bioversys tuberculosis combo targets drug resistance
In the clinic for Feb. 20, 2026
In the clinic for Feb. 20, 2026
Other news to note for Feb. 20, 2026
Other news to note for Feb. 20, 2026
Regulatory actions for Feb. 20, 2026
Regulatory actions for Feb. 20, 2026
Biopharma money raised: Jan. 1-Feb. 19, 2026
Biopharma money raised: Jan. 1-Feb. 19, 2026
Money raised by biopharma
Money raised by biopharma
Supreme Court rules against Trump tariffs
Supreme Court rules against Trump tariffs
2025 report: Spain’s Catalonia region a European life sciences leader
2025 report: Spain’s Catalonia region a European life sciences leader
Hangzhou Innogate Pharma discloses cGAS inhibitors
Hangzhou Innogate Pharma discloses cGAS inhibitors
NRF2 inhibitors reported in Genfleet Therapeutics patent
NRF2 inhibitors reported in Genfleet Therapeutics patent
Beijing Konruns Pharmaceutical discovers TACC inhibitors
Beijing Konruns Pharmaceutical discovers TACC inhibitors
Shanghai Fudan Zhangjiang Biopharmaceutical synthesizes new compounds for cancer
Shanghai Fudan Zhangjiang Biopharmaceutical synthesizes new compounds for cancer
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page